scholarly journals Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)

2017 ◽  
Vol 215 (7) ◽  
pp. 1085-1093 ◽  
Author(s):  
Heng Chi ◽  
Bettina E. Hansen ◽  
Simin Guo ◽  
Ning Ping Zhang ◽  
Xun Qi ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Controlled Trial ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Virus Envelope ◽  
Randomized Controlled ◽  
B Virus ◽  
Positive Chronic Hepatitis ◽  
Pegylated Interferon Alfa ◽  
Envelope Antigen

scholarly journals Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B

Hepatology ◽  
2015 ◽  
Vol 63 (2) ◽  
pp. 377-387 ◽  
Author(s):  
Maureen M. Jonas ◽  
Mei-Hwei Chang ◽  
Etienne Sokal ◽  
Kathleen B. Schwarz ◽  
Deirdre Kelly ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Positive Chronic Hepatitis ◽  
Envelope Antigen

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

The Lancet ◽  
2005 ◽  
Vol 365 (9454) ◽  
pp. 123-129 ◽  
Author(s):  
Harry LA Janssen ◽  
Monika van Zonneveld ◽  
Hakan Senturk ◽  
Stefan Zeuzem ◽  
Ulus S Akarca ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Randomised Trial ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Positive Chronic Hepatitis ◽  
Pegylated Interferon Alfa
Sign in / Sign up

Export Citation Format

Share Document